Delivery Order SPE2DB20D1109-SPE2DB25FP62T
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,304.62 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count units) on July 28, 2025, with an ultimate completion date of July 29, 2025. This firm fixed-price delivery order represents a non-competitive award issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $1 billion global pharmaceutical support vehicle running through December 2026. The place...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $41,696.62 to AmerisourceBergen Drug Corp for NURTEC ODT 75 MG tablets (8-count units) on August 12, 2025, with an ultimate completion date of August 13, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $4,200.07 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count packaging) on August 7, 2025, with an ultimate completion date of August 8, 2025. This is a firm fixed price delivery order with no set-aside designation, issued under a competitive procurement process. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, which serves as the company's distribution hub...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $22,875.33 to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 mg tablets (8-count units). This contract was competitively awarded without set-aside designation and is structured as a firm fixed price delivery order, with an ultimate completion date of August 1, 2025. The award was issued on July 31, 2025, with performance to be fulfilled at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $24,953.82 delivery order to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count packages) on July 22, 2025, with completion scheduled for July 23, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement needs across military and...
- The Defense Logistics Agency awarded a delivery order valued at $49,744.77 to AmerisourceBergen Drug Corp for NURTEC ODT 75 MG tablets (8-count packaging) on July 24, 2025, with completion scheduled for July 25, 2025. This firm fixed-price delivery order carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its Corporate Office location in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $29,813.65 to AmerisourceBergen Drug Corp for 8 tablets of NURTEC ODT 75 mg. This competitive, firm fixed-price delivery order was issued on July 24, 2025, with an ultimate completion date of July 25, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs for military and veteran healthcare systems. The delivery order is...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $9,157.19 to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 mg tablets (8-count units) with an ultimate completion date of August 4, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The contract...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,606.70 to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of NURTEC ODT 75 mg tablets (8-count units). This competitively awarded, firm fixed-price contract reflects no set-aside designation and specifies performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 15, 2025. The delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for supply of NURTEC ODT 75 MG tablets (eight count) with a ceiling value of $10,819.64. This firm fixed price delivery order, awarded on August 18, 2025, with an ultimate completion date of August 19, 2025, represents a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The award was made through competitive procurement with no set-aside designation. AmerisourceBergen Drug...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB25FP62TDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $48,497.72 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count packages) on August 22, 2025, with an ultimate completion date of August 25, 2025. This firm fixed-price, competitively awarded contract contains no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion comprehensive pharmaceutical supply vehicle running through December 2026. AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal medical procurement, supplying brand-name and generic medications to military and veteran healthcare systems through the DLA Medical Supply Chain. NURTEC ODT is a migraine treatment medication, reflecting the company's broad portfolio of neurological and specialty pharmaceuticals delivered to support Defense Health Agency requirements and other federal healthcare programs. The delivery order demonstrates AmerisourceBergen's established capability to fulfill federal pharmaceutical needs through open competition, as evidenced by its consistent award history with the DLA across multiple therapeutic domains and transaction values.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $48.5k | 8/22/25 |